MBiotech Program News
16/11/2011 - 12:00 -
Drug development risk in HIV-1 clinical trials: the effect of drug class
Published by: Brendan J.W. Osborne, Rupert Kaul and Jayson L. Parker
Brendan Osborne conducted this research as part of his training in the MBiotech Program. He is now conducting his Ph.D. in the Institute of Medical Science at the University of Toronto, on HIV infection.
Click here to view the journal article.
08/09/2011 - 13:00 -
Medical Device Market Access Conference
MBiotech team work featured in conference session
The upcoming Medical Device Market Access Conference in Canada will have a session presented by Dr. Jayson Parker based on work with the MBiotech student team on portable ultrasound reimbursement challenges. The student team includes: Sonia Syed, Sudagar Dhailwal, Niroshan Sriskandarajah,...
28/07/2011 - 09:00 -
10th Annual Master of Biotechnology Program Internship Day
The 10th Annual Master of Biotechnology Program Internship Day
Provides an opportunity for:
Company representatives to promote their companies to the MBiotech students
Potential employers to learn more about the Master of Biotechnology Internship program
Industry partners to meet the Class of 2013 who will be available for...
15/06/2011 - 14:00 -
MBiotech student publishes on clinical trial failure rate in Lymphoma
Clinical Trial Risk in Non-Hodgkin's Lymphoma: Endpoint and Target Selection
Ms. Zoe Zhang conducted research on clinical trail failure rates in lymphoma while an MBiotech student. Her work has now been published in a peer reviewed journal and is entitled "Clinical Trial Risk in Non-Hodgkin's Lymphoma: Endpoint and Target...
09/08/2010 - 11:00 -
Pharmacists get Schooled!
Associate Director Leigh Revers participates in the Canadian Society of Hospital Pharmacists' 63rd Summer Educational Sessions in Halifax, Nova Scotia as part of a presentation session entitled "The Paradox of Subsequent Entry Biologicals: A Non-Bioequivalent Generic" hosted by Janssen-Ortho Inc.
Alongside other speakers from Amgen...